ApiFix Ltd. is a wholly-owned subsidiary of OrthoPediatrics Corp. www.orthopediatrics.com

ApiFix, The Internal Brace Option, and Refuse to Fuse are trademarks of ApiFix Ltd. ApiFix is a registered trademark in the United States.

The ApiFix procedure is classified as a humanitarian use device authorized by U.S. federal law for use in the treatment of adolescent idiopathic scoliosis (AIS). The effectiveness of this device for this use has not been demonstrated. Federal law restricts this device to sale by or on the order of a physician.

Advancing scoliosis treatment, empowering patients

Our mission is to positively impact the lives of young patients with scoliosis by expanding the range of available treatment options.

Giving patients a viable, new alternative

Adolescents diagnosed with progressive scoliosis have been faced with limited treatment options. Wearing a brace can be uncomfortable and can limit participating in activities. Fusion is a permanent step in an adolescent’s life. We developed the ApiFix^® procedure to change this paradigm by providing a treatment that enables patients to live their lives the way they want – actively.

Backed by an industry leader

ApiFix is a wholly owned subsidiary of OrthoPediatrics Corp. (Nasdaq: KIDS), focused exclusively on advancing the field of pediatric orthopedics and improving the lives of children with orthopedic conditions.

LEARN MORE ABOUT ORTHOPEDIATRICS

ApiFix Ltd. Memberships

Contact supplier